Du surfar just nu på en begränsad version av umu.se. Vad innebär det här?

"False"
Umeå universitet
printicon
Huvudmenyn dold.
Personalbild Anna Bengtsson

Anna Bengtsson

Kontakt

E-post
anna.bengtsson@umu.se

Verksam som

Anknytning
Adjungerad universitetsadjunkt vid Institutionen för folkhälsa och klinisk medicin Enhet: Allmänmedicin
Plats
Byggnad 5B, plan 5, målpunkt PA, Norrlands universitetssjukhus, Försörjningsv. 7B Umeå universitet, 901 85 Umeå
Multi-view carotid ultrasound is stronger associated with cardiovascular risk factors than presence of plaque or single carotid intima media thickness measurements in subclinical atherosclerosis
The International Journal of Cardiovascular Imaging, Springer Nature 2023, Vol. 39, (8) : 1461-1471
Bengtsson, Anna; Nyman, Emma; Grönlund, Christer; et al.
Reduced progression of carotid intima media thickness by personalised pictorial presentation of subclinical atherosclerosis in VIPVIZA: A randomised controlled trial
Clinical Physiology and Functional Imaging, John Wiley & Sons 2023, Vol. 43, (4) : 232-241
Nyman, Emma; Grönlund, Christer; Vanoli, Davide; et al.
Pictorial presentation of subclinical atherosclerosis: a measure to reduce the risk for cardiovascular disease
Umeå University medical dissertations, 2144
Bengtsson, Anna
Increased knowledge makes a difference!–general practitioners’ experiences of pictorial information about subclinical atherosclerosis for primary prevention: an interview study from the VIPVIZA trial
Scandinavian Journal of Primary Health Care, Taylor & Francis 2021, Vol. 39, (1) : 77-84
Bengtsson, Anna; Lindvall, Kristina; Norberg, Margareta; et al.
The beneficial effect over 3 years by pictorial information to patients and their physician about subclinical atherosclerosis and cardiovascular risk: results from the VIPVIZA randomized clinical trial
American Journal of Preventive Cardiology, Elsevier 2021, Vol. 7
Bengtsson, Anna; Norberg, Margareta; Ng, Nawi; et al.
Visualization of asymptomatic atherosclerotic disease for optimum cardiovascular prevention (VIPVIZA): a pragmatic, open-label, randomised controlled trial
The Lancet, Elsevier 2019, Vol. 393, (10167) : 133-142
Näslund, Ulf; Ng, Nawi; Lundgren, Anna; et al.
Association of cardiovascular disease risk factors with combined carotid ultrasound measurements in subclinical atherosclerosis
Bengtsson, Anna; Nyman, Emma; Grönlund, Christer; et al.
Reduced progression of carotid intima media thickness by pictorial presentation of subclinical atherosclerosis in VIPVIZA – a randomized controlled trial
Nyman, Emma; Grönlund, Christer; Vanoli, Davide; et al.
Visa publikationer i DiVA

Forskningsprojekt

15 juni 2022 till 31 december 2030
Riskmarkörer för framtida hjärt- kärl- och lungsjukdom.
1 januari 2018 till 30 december 2024
Minskat stillasittande på arbetet med stöd av mHälsa (mobil hälsa)
29 april 2013 till 31 december 2027
VIPVIZA